I FARMACI ANTIEPILETTICI COME 'MARKERS' PER LO STUDIO DELLA PREVALENZA DELL'EPILESSIA

E. Beghi; M. L. Monticelli; D. Trevisan; M. Zarrelli; F. Apollo; P. Di Viesti; A. Franza; M. Porta; P. Simone; P. Tonali

I FARMACI ANTIEPILETTICI COME 'MARKERS' PER LO STUDIO DELLA PREVALENZA DELL'EPILESSIA

Translated title of the contribution: Antiepileptic drugs as 'tracers' for the study of the prevalence of epilepsy

E. Beghi, M. L. Monticelli, D. Trevisan, M. Zarrelli, F. Apollo, P. Di Viesti, A. Franza, M. Porta, P. Simone, P. Tonali

Istituto di Ricerche Farmacologiche "Mario Negri"

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Abstract

In a population of 51220 from three geographic areas, all the patients treated with antiepileptic drugs (AED) seen by the local general practitioners (GP) were examined by a neurologist to check the appropriateness of AED as 'markers' of epilepsy, to calculate the crude prevalence rate of the disease, and to assess the quality of care to patients of epilepsy in clinical practice. The diagnosis of epilepsy was confirmed in 199 out of 209 patients taking AED. Thus, drugs are rather sensitive 'markers' of epilepsy. Yet, the prevalence of epilepsy so calculated (3.89 cases per 1000) was significantly lower than that found with different methods of case ascertainment (including information from drug sales), suggesting a low access rate to GP by patients with epilepsy. Our findings tend also to support the evidence that monitoring and management of epilepsy in clinical practice do not aways reflect the common standards of the literature.

Translated title of the contribution	Antiepileptic drugs as 'tracers' for the study of the prevalence of epilepsy
Original language	Italian
Title of host publication	Bollettino - Lega Italiana contro l'Epilessia
Pages	327-328
Number of pages	2
Edition	66-67
Publication status	Published - 1989

ASJC Scopus subject areas

Clinical Neurology

Cite this

I FARMACI ANTIEPILETTICI COME 'MARKERS' PER LO STUDIO DELLA PREVALENZA DELL'EPILESSIA. / Beghi, E.; Monticelli, M. L.; Trevisan, D.; Zarrelli, M.; Apollo, F.; Di Viesti, P.; Franza, A.; Porta, M.; Simone, P.; Tonali, P.

Bollettino - Lega Italiana contro l'Epilessia. 66-67. ed. 1989. p. 327-328.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

@inproceedings{eab6a8ece185442a9af7991049887bba,

title = "I FARMACI ANTIEPILETTICI COME 'MARKERS' PER LO STUDIO DELLA PREVALENZA DELL'EPILESSIA",

abstract = "In a population of 51220 from three geographic areas, all the patients treated with antiepileptic drugs (AED) seen by the local general practitioners (GP) were examined by a neurologist to check the appropriateness of AED as 'markers' of epilepsy, to calculate the crude prevalence rate of the disease, and to assess the quality of care to patients of epilepsy in clinical practice. The diagnosis of epilepsy was confirmed in 199 out of 209 patients taking AED. Thus, drugs are rather sensitive 'markers' of epilepsy. Yet, the prevalence of epilepsy so calculated (3.89 cases per 1000) was significantly lower than that found with different methods of case ascertainment (including information from drug sales), suggesting a low access rate to GP by patients with epilepsy. Our findings tend also to support the evidence that monitoring and management of epilepsy in clinical practice do not aways reflect the common standards of the literature.",

author = "E. Beghi and Monticelli, {M. L.} and D. Trevisan and M. Zarrelli and F. Apollo and {Di Viesti}, P. and A. Franza and M. Porta and P. Simone and P. Tonali",

year = "1989",

language = "Italian",

pages = "327--328",

booktitle = "Bollettino - Lega Italiana contro l'Epilessia",

edition = "66-67",

}

TY - GEN

T1 - I FARMACI ANTIEPILETTICI COME 'MARKERS' PER LO STUDIO DELLA PREVALENZA DELL'EPILESSIA

AU - Beghi, E.

AU - Monticelli, M. L.

AU - Trevisan, D.

AU - Zarrelli, M.

AU - Apollo, F.

AU - Di Viesti, P.

AU - Franza, A.

AU - Porta, M.

AU - Simone, P.

AU - Tonali, P.

PY - 1989

Y1 - 1989

N2 - In a population of 51220 from three geographic areas, all the patients treated with antiepileptic drugs (AED) seen by the local general practitioners (GP) were examined by a neurologist to check the appropriateness of AED as 'markers' of epilepsy, to calculate the crude prevalence rate of the disease, and to assess the quality of care to patients of epilepsy in clinical practice. The diagnosis of epilepsy was confirmed in 199 out of 209 patients taking AED. Thus, drugs are rather sensitive 'markers' of epilepsy. Yet, the prevalence of epilepsy so calculated (3.89 cases per 1000) was significantly lower than that found with different methods of case ascertainment (including information from drug sales), suggesting a low access rate to GP by patients with epilepsy. Our findings tend also to support the evidence that monitoring and management of epilepsy in clinical practice do not aways reflect the common standards of the literature.

AB - In a population of 51220 from three geographic areas, all the patients treated with antiepileptic drugs (AED) seen by the local general practitioners (GP) were examined by a neurologist to check the appropriateness of AED as 'markers' of epilepsy, to calculate the crude prevalence rate of the disease, and to assess the quality of care to patients of epilepsy in clinical practice. The diagnosis of epilepsy was confirmed in 199 out of 209 patients taking AED. Thus, drugs are rather sensitive 'markers' of epilepsy. Yet, the prevalence of epilepsy so calculated (3.89 cases per 1000) was significantly lower than that found with different methods of case ascertainment (including information from drug sales), suggesting a low access rate to GP by patients with epilepsy. Our findings tend also to support the evidence that monitoring and management of epilepsy in clinical practice do not aways reflect the common standards of the literature.

UR - http://www.scopus.com/inward/record.url?scp=0024808984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024808984&partnerID=8YFLogxK

M3 - Contributo a conferenza

AN - SCOPUS:0024808984

SP - 327

EP - 328

BT - Bollettino - Lega Italiana contro l'Epilessia

ER -

I FARMACI ANTIEPILETTICI COME 'MARKERS' PER LO STUDIO DELLA PREVALENZA DELL'EPILESSIA

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this